Sputnik V vaccine confusion reignites suspicions over Jubilee party

摘要

Since 10 April, Kenyan firm Dinlas Pharma has been struggling to obtain the necessary authorisations to reexport 75,000 doses of the Russian Sputnik V vaccines. The company is seeking to sell its doses as it can no longer use them since the health ministry banned Sputnik V on 2 April, shortly after the company obtained a short-lived license from the national drug regulator Pharmacy and Poisons Board (PPB) to distribute the vaccine.